Mesalamine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Mesalamine. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 36% |
| Abdominal pain | 18% |
| Eructation | 16% |
| Nausea | 15% |
| Asthenia | 15% |
| Pain | 14% |
| Pharyngitis | 11% |
| Diarrhea | 9% |
| Dizziness | 8% |
| Fever | 8% |
| Back pain | 7% |
| Flatulence | 7% |
| Rash | 6% |
| Dyspepsia | 6% |
| Rhinitis | 5% |
| Arthralgia | 5% |
| Hypertonia | 5% |
| Vomiting | 5% |
| Constipation | 5% |
| Dysmenorrhea | 3% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.
Source: FDA labeling via NIH DailyMed (set 83864c82…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.